Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Insiders Are Excited About This Aerospace Company

On September 28th, Marcia Mason, the General Counsel of Esterline Technologies Corporation (NYSE:ESL), directly acquired 2,500 shares at an average price of $56.17 per share. At Insider Monkey we track insider transactions because on a statistical basis stocks bought by insiders tend to outperform the market (read our discussion of studies on insider trading). In theory, insiders should be wary of buying their company’s stock; their future income is already dependent on its prospects, so why tie a significant portion of their wealth to it as well? The answer- which explains the outperformance of insider buys- is that the insiders are signaling high confidence in the stock. This is particularly the case when we see consensus insider buying. That’s exactly what we’ve seen at Esterline, though Mason’s purchase was the largest. At prices generally between $57 and $58, three Board members bought a total of 4,000 shares between September 24th and September 28th.

Esterline Technologies Corporation (NYSE:ESL)

The $1.8 billion market cap Esterline Technologies Corporation provides controls, instruments, and sensors for civilian and defense aircraft. In the third quarter of its fiscal year (the quarter ended in July), the company reported a 19% increase in revenue over the same period a year ago. However, costs increased and it also took a goodwill impairment of $52 million, which together drove the company to a $17 million net loss for the quarter (it had earned $38 million in the third fiscal quarter of last year). For the first nine months of the fiscal year, Esterline was down to $51 million in earnings from $114 million at the same point in 2011. Again, the (presumably non-recurring) goodwill impairment was responsible for most of this decline, but costs ex-impairment had driven down profits as well.

Esterline Technologies Corporation trades at a trailing P/E multiple of 26. Wall Street analysts expect performance to pick up in the next fiscal year (and certainly we would hope that there would be no goodwill impairment), and the forward P/E is a fairly reasonable 10. This puts it in value territory if it lives up to analyst expectations. Investors should also consider that while Esterline’s beta of 1.5 is indeed high and indicates that the stock tends to fluctuate to a greater degree than the market, it is not as high as might be worried when considering an aerospace-focused company. Ralph Whitworth’s Relational Investors increased its stake in Esterline by 41% during the second quarter, finishing June with a total of 2.2 million shares. This gave Relational a position in the company worth over $100 million (see more stocks Relational has over $100 million invested in).

Curtiss-Wright Corp. (NYSE:CW) and Eaton Corporation (NYSE:ETN) are good peers for Esterline, and we would also compare the company to Kaman Corporation (NYSE:KAMN) and HEICO Corporation (NYSE:HEI). The first two companies are about as cheap as Esterline on a forward basis: Curtiss-Wright and Eaton trade at 11 and 10 times their respective forward earnings estimates. However, they both carry trailing P/Es of 11, so even taking into account the special factors that drove down Esterline’s recent earnings it seems to be a worse buy. Kaman and HEICO are at the growth end of the spectrum. They are more expensive than Curtiss-Wright or Eaton on a trailing earnings basis, in the 20-26 range of trailing P/Es, but can justify that premium by pointing to double-digit earnings growth rates last quarter compared to the same period in 2011. Continued growth, however, isn’t quite enough to pull them even as Kaman trades at a forward P/E of 13 while HEICO’s multiple is 21. So, from a value perspective, we would prefer to own Curtiss-Wright or Eaton out of these five companies. They look good on a forward basis, and unlike Esterline are already delivering much of the earnings they are expected to have in the coming year rather than relying on growth. Unless an investor puts a good deal of weight on chasing insider buys- which admittedly on a large scale should tend to be a good strategy- they are probably the best buys.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!